493P_PR - A prospective study on quality of life among persons with lung cancer, before and after chemotherapy treatment – evidence from South India

Date 18 December 2016
Event ESMO Asia 2016 Congress
Session Poster lunch
Topics Psychosocial Aspects of Cancer
Palliative Care
Thoracic Malignancies
Presenter Sabin Katpattil
Citation Annals of Oncology (2016) 27 (suppl_9): ix157-ix160. 10.1093/annonc/mdw595
Authors S. Katpattil
  • General Medicine, AL IQBAL HOSPITAL AND RESEARCH CENTRE, 670687 - Kerala/IN



Lung cancer is usually diagnosed at an advanced stage and survival has not improved in spite of several therapeutic advancements. Since most patients depend on palliative care, it is imperative to evaluate and maintain a satisfactory quality of life in them.


The QLRH was assessed using the questionnaires Quality-of-Life Questionnaire-Core 30 (QLQ-C30) and Lung Cancer Module (LC13), version 3.0.


The sample was made up of 88 women and 99 men, with an average age of 68 years (51-87 years). After chemotherapy treatment, a clinically relevant improvement in general quality of life, as well as in the symptoms of dyspnoea, insomnia, haemoptysis, cough, thoracic pain, pain in the arm/shoulder, and financial difficulty was observed. There was a worsening on the functional scale which assesses role performance and symptoms of fatigue, nausea and vomiting, sensory neuropathy, pain in other parts, constipation, loss of appetite and alopecia.


Although the patients have an improvement of their QLRH and symptoms related to the lung cancer after the chemotherapy treatment, there was a worsening of the symptoms which resulted from the toxicity of the chemotherapy medications.

Clinical trial indentification


Legal entity responsible for the study



Al Iqbal Hospital and Research Centre


All authors have declared no conflicts of interest.